Due diligence in Diagnostics for ABN Amro to acquire AES Laboratories

Situation

• ABN AMRO was considering a Public-to-Private LBO of AES Laboratoire, a leading French company in microbiological diagnostics

1. Total revenues of €69 million
2. Over 270 employees

• ABN AMRO mandated Bionest to assess and validate the projected transaction

Bionest Contribution

• Bionest built an ad-hoc team of dedicated experts in relevant fields to provide detailed recommendations

1. Business plan validation based on in-depth analysis of AES markets, particularly bovine spongiform encephalopathy
2. Positioning of AES and strategic recommendations
3. Company organization and management team assessment

Key Results

• Specific and relevant answers to customer needs...
• ...based on a rapid mobilization of Bionest resources and a well-tried process